Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus ... particularly B-cell depleting agents like rituximab, or disease. HBsAg-positivity also confers ...

A role for rituximab in depleting B cells and compromising their antigen ... Type II mixed essential CRYOGLOBULINEMIA (MEC) is often associated with hepatitis C virus (HCV) infection, and leads ...

Those who are hepatitis B surface antigen-positive are eligible for enrollment ... A study to evaluate zilovertamab vedotin (mk-2140) combination with rituximab plus cyclophosphamide, doxorubicin, and ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, researchers have identified a vulnerability that opens ...

Dynavax reports record HEPLISAV-B revenue, 26% growth in 2024, and strong 2025 guidance. Insights on shingles vaccine progress & market expansion.

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

Precision BioSciences reports early PBGENE-HBV trial data showing safety and antiviral activity in chronic Hepatitis B patients, with more results expected in 2025.

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

As the number of immunosuppressive drugs has grown, so has the number of patients referred to gastroenterologists with hepatitis B reactivation, which can lead to acute liver failure. For patients ...

The NHS will automatically test patients for HIV, Hepatitis B and Hepatitis C unless they opt out at almost 90 Accident and Emergency (A&E) units in England, the BBC can reveal. The government is ...